ICMR issues advisory on use of CBNAAT for Coronavirus testing, details
According to the advisory, any laboratory, already functional for SARS-CoV-2 testing by real-time PCR with appropriate BSL-2 setup, may start testing using Xpert Xpress SARS-CoV-2 without any further approval from the ICMR.
New DelhiL The Indian Council of Medical Research (ICMR), here on Monday, issued an advisory on use of cartridge-based nucleic acid amplification test (CBNAAT) using Cepheid's Xpert Xpress SARS-CoV-2 test.
It has invited applications from laboratories for use of this testing method. Any testing with the Cepheid's Xpert Xpress SARS-CoV-2 is done under the biosafety 2 level (BSL-2) conditions and with appropriate precautions.
The CBNAAT is a recently introduced polymerase chain raction-based (PCR) method for detection of mycobacterium tuberculosis.
The Xpert Xpress SARS-CoV-2 test is a rapid, real-time RT-PCR test aimed at the qualitative detection of nucleic acid from the SARS-CoV-2 in either nasopharyngeal, nasal, or mid-turbinate swab and/or nasal wash/aspirate specimens collected from individuals suspected of Covid-19 by their healthcare provider.
It's a FDA approved testing system for use under the emergency use authorisation (EUA) only.
According to the advisory, any laboratory, already functional for SARS-CoV-2 testing by real-time PCR with appropriate BSL-2 setup, may start testing using Xpert Xpress SARS-CoV-2 without any further approval from the ICMR.
However, the test results will have to be uploaded on the ICMR Covid-19 portal.
The ICMR said any new government laboratory seeking to initiate the CBNAAT must meet the minimum ICMR requirements such as availability of a BSL-2 level laboratory facility, including a molecular biology setup for virological diagnosis and a functioning and calibrated biosafety cabinet type 2A/2B in the laboratory, staff having experience in molecular virology, a robust institutional policy on biomedical waste management of human origin and well-defined arrangement for segregation and discarding of biomedical waste.
Private laboratories that intended the CBNAAT should have the National Accreditation Board for Testing & Calibration Laboratories (NABL) accreditation for molecular detection of RNA viruses either by the real-time PCR or the CBNAAT, the apex medical research body added.
Read also: Karnataka slashes Private lab coronavirus test rates to Rs 2,250
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.